» Articles » PMID: 31794028

Lung Ultrasound B-lines and Serum KL-6 Correlate with the Severity of Idiopathic Inflammatory Myositis-associated Interstitial Lung Disease

Overview
Specialty Rheumatology
Date 2019 Dec 4
PMID 31794028
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Idiopathic inflammatory myositis-associated interstitial lung disease (IIM-ILD) significantly increases morbidity and mortality. Lung ultrasound B-lines and Krebs von den Lungen-6 (KL-6) are identified as new sonographic and serum markers of ILD, respectively. The aim of our work was to assess the role of B-lines and KL-6 as markers of the severity of IIM-ILD. For this purpose, the correlation among B-lines score, serum KL-6 levels, high-resolution CT (HRCT) score, and pulmonary function tests were investigated in IIM-ILD patients.

Methods: Thirty-eight patients with IIM-ILD underwent chest HRCT scans, lung ultrasound and pulmonary function tests (independently performed within 1 week) examination. To assess severity and extent of ILD at HRCT, the Warrick score was used. The B-lines score denoting the extension of ILD was calculated by summing the number of B-lines on a total of 50 scanning sites. Serum KL-6 levels (U/ml) was measured by chemiluminescent enzyme immunoassay.

Results: A significant correlation was found between the B-lines score and serum KL-6 levels (r = 0.43, P < 0.01), and between the Warrick score and serum KL-6 levels (r = 0.45, P < 0.01). A positive correlation between B-lines score and the Warrick score (r = 0.87, P < 0.0001) was also confirmed. Both B-lines score and KL-6 levels inversely correlated to diffusion capacity for carbon monoxide (r = -0.77, P < 0.0001 and r = -0.42, P < 0.05, respectively) and total lung capacity (r = -0.73, P < 0.0001 and r = -0.36, P < 0.05, respectively). Moreover, B-lines correlated inversely with forced vital capacity (r = -0.73, P < 0.0001), forced expiratory volume in 1 s (r = -0.69, P < 0.0001).

Conclusion: B-lines score and serum KL-6 levels correlate with HRCT findings and pulmonary function tests, supporting their use as measures of IIM-ILD severity.

Citing Articles

A versatile role for lung ultrasound in systemic autoimmune rheumatic diseases related pulmonary involvement: a narrative review.

Wang Y, Chen S, Zheng S, Zhou Z, Zhang W, Du G Arthritis Res Ther. 2024; 26(1):164.

PMID: 39294670 PMC: 11409780. DOI: 10.1186/s13075-024-03399-2.


Predictors of progression in idiopathic inflammatory myopathies with interstitial lung disease.

Cao H, Huang J, Chang J, Zhu Y, Liang J, Sun C J Transl Int Med. 2023; 11(1):46-56.

PMID: 37533847 PMC: 10393057. DOI: 10.2478/jtim-2022-0029.


KL-6 levels in the connective tissue disease population: typical values and potential confounders-a retrospective, real-world study.

Zhou A, Tang H, Peng W, Wang Y, Tang X, Yang H Front Immunol. 2023; 14:1098602.

PMID: 37409133 PMC: 10318146. DOI: 10.3389/fimmu.2023.1098602.


Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease.

Pugashetti J, Khanna D, Kazerooni E, Oldham J Immunol Allergy Clin North Am. 2023; 43(2):411-433.

PMID: 37055096 PMC: 10584384. DOI: 10.1016/j.iac.2023.01.012.


Serum B-cell activating factor and lung ultrasound B-lines in connective tissue disease related interstitial lung disease.

Wang Y, Xie X, Zheng S, Du G, Chen S, Zhang W Front Med (Lausanne). 2023; 9:1066111.

PMID: 36590969 PMC: 9798453. DOI: 10.3389/fmed.2022.1066111.


References
1.
Gargani L, Doveri M, dErrico L, Frassi F, Bazzichi M, Delle Sedie A . Ultrasound lung comets in systemic sclerosis: a chest sonography hallmark of pulmonary interstitial fibrosis. Rheumatology (Oxford). 2009; 48(11):1382-7. DOI: 10.1093/rheumatology/kep263. View

2.
Kubo M, Ihn H, Yamane K, Kikuchi K, Yazawa N, Soma Y . Serum KL-6 in adult patients with polymyositis and dermatomyositis. Rheumatology (Oxford). 2000; 39(6):632-6. DOI: 10.1093/rheumatology/39.6.632. View

3.
Bandoh S, Fujita J, Ohtsuki Y, Ueda Y, Hojo S, Tokuda M . Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis. Ann Rheum Dis. 2000; 59(4):257-62. PMC: 1753113. DOI: 10.1136/ard.59.4.257. View

4.
Volpicelli G, Elbarbary M, Blaivas M, Lichtenstein D, Mathis G, Kirkpatrick A . International evidence-based recommendations for point-of-care lung ultrasound. Intensive Care Med. 2012; 38(4):577-91. DOI: 10.1007/s00134-012-2513-4. View

5.
. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000; 161(2 Pt 1):646-64. DOI: 10.1164/ajrccm.161.2.ats3-00. View